STAT Plus: Startup Spotlight: Going after immune regulators when they cause disease instead of prevent it
Q32 Bio has two targets in its sights: the two arms of the immune system….
Category: Boston
Hospital records hold valuable Covid-19 data. Making it usable is time-consuming work
As tens of thousands of people worldwide test positive for Covid-19 every day, researchers are…
STAT Plus: ‘One thing cancer patients don’t generally have is time’: New cancer research leader brings urgency to Sanofi
Peter Adamson joined Sanofi in late March, as the coronavirus pandemic surged around the world…
Vaccine experts say Moderna didn’t produce data critical to assessing Covid-19 vaccine
Heavy hearts soared Monday with news that Moderna’s Covid-19 vaccine candidate — the frontrunner in the…
STAT Plus: Prominent Broad Institute scientist leaves to lead R&D at Genentech
A star scientist in the world of single-cell genomics and computational biology is leaving academia…
STAT Plus: Dyne Therapeutics and three other startups got venture funding a year ago. Will it be enough to get them through Covid-19?
How a venture-backed startup gets its money is suddenly more fraught than it used to…
Photos: A peek inside one Boston hospital’s response to Covid-19
This is one in a series of reports from hospitals responding to the Covid-19 pandemic. When he…
Using human brain tissue in lab dishes, researchers show herpes link to Alzheimer’s
A small 3D version of the human brain develops key features of Alzheimer’s disease when…
Mounting promises on Covid-19 vaccines are fueling false expectations, experts say
Vaccines to prevent Covid-19 infection are hurtling through development at speeds never before seen. But…
STAT Plus: Akebia’s experimental pill meets anemia, heart-safety goals in two late-stage clinical trials
Akebia Therapeutics said Tuesday that its experimental anemia pill achieved the primary efficacy and heart-safety…
STAT Plus: Cellular ‘backpacks’ keep immune cells in attack mode against tumors
In a study recently published in Science Advances, Samir Mitragotri’s team at Harvard’s Wyss Institute…
A cancer patient reconsiders her end-of-life wishes, as Covid-19 brings mortality into sharper focus
Even before she knew what kind of cancer she had, Robin Hodges knew she didn’t…
Doctors anticipate patient requests for experimental remdesivir before all the evidence comes in
Before Wednesday’s hopeful news about the experimental antiviral remdesivir broke, doctors treating patients hospitalized for…
STAT Plus: Biogen’s blockbuster rare disease drug could be in trouble
The success of Biogen’s spinal muscular atrophy treatment Spinraza has been among the few bright…
STAT Plus: For the first time, a blood test helped doctors find and treat cancers in seemingly healthy people
For the first time, doctors have used the results of a liquid biopsy test to…
STAT Plus: ‘GI tract outside the body’ tests how well oral drugs are absorbed
When people swallow a pill, they expect the medicine to quickly reach the source of…
STAT Plus: Startup TScan signs $30m deal with Novartis
TScan Therapeutics on Wednesday announced a $30 million deal with Swiss pharma giant Novartis (NVS)…
Who gets the last ventilator? Facing the coronavirus, a hospital ponders the unthinkable
This is one in a series of reports from hospitals responding to the Covid-19 pandemic….
Help wanted: Health agencies will need an army of coronavirus trackers
K.J. Seung is surprised to be hiring and training new workers in Boston. His public…
The coronavirus sneaks into cells through a key receptor. Could targeting it lead to a treatment?
Nearly 20 years ago, when a different coronavirus struck, Michael Farzan and his team figured…
MIT’s Koch Institute wins STAT Madness with technology to see tiny ovarian tumors
Carbon nanotubes rule. In this year’s STAT Madness, a bracket-style competition to honor the best…
STAT Plus: Boston Scientific cutting hours and pay as revenue drops
Boston Scientific said Thursday that it’s cutting wages for many of its roughly 36,000 global…
STAT Plus: The latest failure in Alzheimer’s casts doubt on Biogen’s ostensible success
The prevailing theory of how to treat Alzheimer’s disease endured its 1,001st cut on Thursday,…
STAT Plus: Big biotech venture funds raise billions despite coronavirus fears
The economy is grinding to a near-halt because of Covid-19. In the biotechnology sector, which…
Opinion: A radical approach to preventing Covid-19 infection in the homeless
There is only a small window of time in which we can prevent widespread transmission…
With masks dwindling, a hospital’s Covid-19 crisis team searches for a way out
This is one in a series of reports from hospitals responding to the Covid-19 pandemic….
STAT Plus: Digital therapy for chronic insomnia gains FDA signoff
The U.S. Food and Drug Administration has authorized the use of a digital product that…
What it’s like to go into the lab at a biopharma company during the coronavirus pandemic
Like grocery store clerks and Amazon delivery drivers, they’re among the essential workers of the…
STAT Plus: ‘Organ-on-a-chip’ maker Emulate names new CEO, announces new funding
A Boston startup known for its plastic chips that simulate human organs announced the appointment…
STAT Plus: Sage has a backup plan for its depression drug: Three new studies aiming for 2022 approval
After meeting with the Food and Drug Administration, Sage Therapeutics said Wednesday that it will…
STAT Plus: Despite coronavirus disruption, major microbiome companies are cautiously optimistic about upcoming data
This was supposed to be the microbiome’s breakthrough year — and pandemic or not, it…
Hospital in Boston will be converted into Covid-19 treatment center
A Texas-based health care system announced Tuesday that it would convert one of its hospitals…
As coronavirus pandemic worsens, health officials fear nationalization of drugs and supplies
An allegation that the Trump administration tried to secure exclusive rights to the production of…
Her son died. Two decades later, she met the medical student who got his heart
The young man handed her a stethoscope, opened his shirt, and pointed to where she…
STAT Plus: Two dead, four hospitalized after receiving Open Biome stool transplants
Two people died and four were hospitalized after they received stool transplants from OpenBiome, the…
STAT Plus: Kymera announces $102 million in new funding to develop treatments for diseases such as blood cancers
Four years after it was founded, Kymera Therapeutics said Thursday that it has now raised…
STAT Plus: Clinical research company sued over stolen trade secrets after employee filmed dogs used in experiments
Nearly two years ago, Charles River Laboratories (CRL) paid $800 million for a company called…
STAT Plus: The Engine at MIT is revving up the potential of ‘tough tech’
If you happen to bump into Bill Gates or Tim Cook in Central Square in…
STAT Plus: Thermo Fisher buys Dutch diagnostics company for $11.5 billion
Thermo Fisher Scientific (TMO) is buying the Dutch diagnostics company Qiagen (QGEN) in an $11.5…
STAT Plus: Cancer biotech gets another new name (now it’s called Xilio) and more than $100 million
For the second time in less than two years, Akrevia Therapeutics has changed its name, in…
STAT Plus: Something Ventured: Vor Biopharma and 3 other startups got venture funding a year ago. Did it help them do what they said it would?
This story is part of STAT’s quarterly series Something Ventured, which looks at early-stage startups….
Opinion: Quarantine for coronavirus? Let’s make that unnecessary
Do you trust the government to protect you and your family from the novel coronavirus…
Biogen, Sangamo partner to develop genome-editing therapies for Alzheimer’s and Parkinson’s disease
The drug maker Biogen announced late Thursday that it would license two preclinical drugs from…
STAT Plus: College student with disease that causes premature aging is heartened by medical advances
In many ways, Emerson College freshman Meghan Waldron seems like a lot of students in…
STAT Plus: Alkermes sued over death of man who overdosed after taking addiction treatment Vivitrol
The parents of a 26-year-old California man who died of an opioid overdose have sued…
STAT Plus: New partnership tries to make up for missing drug data in cost-effectiveness analyses
The Institute for Clinical and Economic Review, ICER, a nonprofit that has become a central…
STAT Plus: In a cramped Kendall Square, biotech startups sublet desks and squeeze into shared labs
Before it launched in January, biotech startup EQRx wasn’t quite large enough to justify leasing…
Aided by machine learning, scientists find a novel antibiotic able to kill superbugs in mice
For decades, discovering novel antibiotics meant digging through the same patch of dirt. Biologists spent…
.jpg)
STAT Plus: Biotech founder who said his painkiller would replace opioids sentenced to 7 years in prison
The founder of a biotech who said his company had developed a painkiller that would…
STAT Plus: Microbiome-based drug makers are hoping new late-stage data will pull the field out of the shadows
The microbiome industry is on the cusp of a turning point. Seres Therapeutics, one of…